-ATPase synergistically induce the vascular smooth muscle cell contractile phenotype. Gene transfer of constitutively active I-1 is a promising therapeutic strategy for preventing vascular proliferative disorders. 
V ascular proliferative disorders such as primary atherosclerosis, restenosis after balloon angioplasty, vein-graft disease, and coronary arteriosclerosis are the most common causes of severe cardiovascular diseases, the current leading cause of death in the United States and the predicted number 1 killer worldwide by 2020. 1 Although vascular smooth muscle cells (VSMCs) are normally located in the arterial media and maintained in a contractile nonproliferative state in vivo, injury or mechanical stress of arteries causes migration of VSMCs into the intima layer of the arterial wall, where the VSMCs switch their phenotype and start to proliferate and synthesize extracellular matrix proteins, resulting in expansion of the arterial intima.
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VSMC phenotype switch from a contractile/quiescent to a proliferative/synthetic one is associated with alterations of many components of the VSMC Ca 2+ signaling network. 6 These changes in VSMC phenotype have been well characterized at the level of contractile proteins 7 and more recently at the level of Ca 2+ handling proteins. 8 Indeed, expression levels of the L-type Ca 2+ channel, sarco/endoplasmic reticulum Background-Phenotypic modulation or switching of vascular smooth muscle cells from a contractile/quiescent to a proliferative/synthetic phenotype plays a key role in vascular proliferative disorders such as atherosclerosis and restenosis. Although several calcium handling proteins that control differentiation of smooth muscle cells have been identified, the role of protein phosphatase inhibitor 1 (I-1) in the acquisition or maintenance of the contractile phenotype modulation remains unknown. Methods and Results-In human coronary arteries, I-1 and sarco/endoplasmic reticulum Ca 2+ -ATPase expression is specific to contractile vascular smooth muscle cells. In synthetic cultured human coronary artery smooth muscle cells, protein phosphatase inhibitor 1 (I-1 target) is highly expressed, leading to a decrease in phospholamban phosphorylation, sarco/endoplasmic reticulum Ca 2+ -ATPase, and cAMP-responsive element binding activity. I-1 knockout mice lack phospholamban phosphorylation and exhibit vascular smooth muscle cell arrest in the synthetic state with excessive neointimal proliferation after carotid injury, as well as significant modifications of contractile properties and relaxant response to acetylcholine of femoral artery in vivo. Constitutively active I-1 gene transfer decreased neointimal formation in an angioplasty rat model by preventing vascular smooth muscle cell contractile to synthetic phenotype change.
Conclusions-I-1 and sarco/endoplasmic reticulum Ca
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(SR) Ca
2+
-ATPase (SERCA2a), and ryanodine receptor are decreased in synthetic VSMCs. [8] [9] [10] [11] [12] Importantly, a sustained increase in cytosolic Ca 2+ is necessary to activate calcineurin, a Ca 2+ /calmodulin-dependent serine/threonine-specific protein phosphatase 2B, which dephosphorylates many proteins, including nuclear factor of activated T cell (NFAT) , that may translocate to the nucleus 13 and induce VSMC proliferation. 14 Recently, we demonstrated that Ca 2+ cycling in contractile VSMCs requires the expression of the SERCA2a isoform, whereas the Ca 2+ cycling in synthetic VSMCs is associated only with the expression of the ubiquitous isoform SERCA2b. 15 Phospholamban (PLB), a negative regulator of SERCA2 activity, is inhibited by protein kinase A (PKA) phosphorylation and activated by protein phosphatase 1 (PP1)-dependent dephosphorylation. 16 However, inhibitor 1 (I-1), a ubiquitously expressed 28-kDa protein, is a highly specific inhibitor of PP1 that enhances both PKA-dependent PLB phosphorylation and therefore SERCA2 activity. [17] [18] [19] [20] [21] I-1 is a major player in multiple neurohormonal pathways associated with Ca 2+ homeostasis and contractile function. On stimulation, PKA phosphorylates Thr35 in I-1, resulting in PP1 inhibition and amplification of the contractile response. 17, 21, 22 Inactivation of I-1 occurs by dephosphorylation of Thr35 by protein phosphatase 2A and 2B, leading to the reversal of PP1 inhibition and restoration of basal function. 23, 24 I-1 can also be phosphorylated at Ser67 and Thr75 by phosphokinase C, but these phosphorylations enhance PP1 activity and diminish contractility. [25] [26] [27] In VSMCs, regulation of phosphoprotein phosphatases has been shown to be a major component in the Ca 2+ sensitization of contraction.
28
Of relevance, I-1 is present in VSMCs
29
; however, studies of its role in modulating VSMC function have provided conflicting results. 20, 30 In light of the high expression of I-1 in these cells, other functions for I-1 in VSMCs are a strong possibility.
The goal of this study was to elucidate the role of PKA signaling enhancer I-1 in the control of VSMC Ca 2+ cycling and phenotypic modulation. Here, we demonstrate that I-1 and SERCA2a act synergistically on Ca 2+ cycling and contribute directly to the VSMC contractile phenotype. Gene transfer of constitutively active I-1 (I-1c) may be a promising therapeutic strategy for preventing vascular proliferative disorders.
Methods
Please refer to the expanded Methods section in the online-only Data Supplement for a detailed description.
Human Samples
Fragments of the left anterior descending coronary artery were dissected from human explanted hearts, and unused segments of left internal mammary artery from 5 patients were obtained during coronary artery bypass from the Surgical Department of the Cardiology Institute at Pitié-Salpêtrière Hospital, Paris, France, in accordance with French bioethical laws (L.1211-3-9). The artery segments were immediately immersed in physiological saline solution, placed at 4°C, and processed within 2 to 3 hours.
Animals
Genetically modified I-1 − / − mice 31 were used. C57 Bl-6 mice (Charles River) of the same age were used as nonlittermate controls. Adult male Sprague-Dawley rats (Charles River) were used for the in vivo carotid injury model and for isolation of aortic VSMCs. Animals were treated according to institutional guidelines.
Measurement of I-I Knockout Femoral Artery Contraction and Relaxation
Mice were anesthetized with a mixture of ketamine (65 mg/kg) and xylazine (13 mg/kg, IP). The left femoral artery was dissected gently, and a 7-0 nylon suture (Ethicon, Johnson & Johnson) was placed under the vessel to serve as reference to calculate vessel diameter. The vessel was equilibrated by adding 100 μL PBS to the perivascular site for 5 minutes. Prostaglandin F2α (1 mmol/L, 100 μL, Sigma P0314) was applied locally on the vessel to contract the artery. After 10 minutes, the prostaglandin F2α solution was removed, and 100 μL acetylcholine (10 -9 to 10 −3 mol/L, Sigma A6625-25G) was added cumulatively to the vessel with 5-minute interval. The change of vessel diameter was recorded with a pixel link camera, and measurements were performed using Image-J.
Measurement of [Ca]
2+ i
Cells were loaded with 2 μmol/L Fura-2-AM for 45 minutes at 37°C and kept in serum-free medium for 30 minutes before experimentation. HEPES buffer (in mmol/L: 116 NaCl, 5. ] i in response to the indicated agonist were calculated either using the ratio 380em/380em (basal) or the ratio (340em/380em)/(340em[basal]/380em [basal]). For each recorded images, 3 distinct regions of interest with no cells were selected, the means of fluorescence measured for these 3 areas were used as a background, and subtraction was applied for each cell measurement before any further calculation.
Statistical Analysis
All quantitative data are presented as the mean±SEM of at least 3 independent experiments. Data were analyzed by use of the KruskalWallis test with a Dunn adjustment for multiple comparisons. Statistical comparisons of 2 groups were analyzed by Wilcoxon matched-pairs signed-rank test or the Mann-Whitney nonparametric test. Linear mixed-effect models with random intercepts were used to analyze the femoral artery contraction and relaxation percent change. Differences were considered significant when P<0.05. Data were analyzed with GraphPad Prism 5 software and IBM SPSS Statistics software.
Results
Regulation of the I-1/PP1/PLB/SERCA Signaling Axis in Contractile Versus Synthetic Human VSMCs
Because VSMCs have the capacity for phenotypic dedifferentiation from a contractile to synthetic phenotype, we assessed whether the I-1/PP1 signaling pathway was modified during this process. First, we analyzed I-1 expression in contractile and synthetic VSMCs from healthy segments of human coronary arteries (hCAs) obtained from 5 patients with dilated (nonischemic) cardiomyopathy. hCAs contain a subendothelial layer of synthetic VSMCs and connective tissue to support the endothelium, whereas the medial layer is composed mainly of contractile VSMCs. 15 I-1 protein was expressed only in the medial layers of hCAs ( Figure 1A and Figure IA in the online-only Data Supplement) and mammary arteries ( Figure  IB in the online-only Data Supplement) and was downregulated in the subendothelial layer ( Figure 1A ) and in the media of atherosclerotic vessels ( Figure IC in the online-only Data Supplement), suggesting that I-1 is specifically highly expressed in contractile VSMCs. 15 Immunoblot analysis Figure 1B and 1C) , whereas its target, total PP1, was upregulated and highly detectable by immunofluorescence in synthetic hCASMCs ( Figure 1B and 1D and Figure IIA in the online-only Data Supplement). Next, we looked to PP1 isoform expression in synthetic versus contractile VSMCs by coimmunostaining with smooth muscle α-actin. PP1α was detected only in the nucleus; however, PP1β was abundantly expressed in synthetic VSMCs with a higher level in the nucleus and in the cytosol compared with the contractile VSMCs ( Figure  IIB and IIC in the online-only Data Supplement, respectively). Consequently, PLB phosphorylation was higher in contractile VSMCs compared with synthetic VSMCs ( Figure 1B and 1E) , without a change in total PLB expression ( Figure 1B and 1F) . Confirming previous observations, SERCA2a was expressed only in contractile VSMCs, 15 whereas SERCA2b expression was similar between contractile and synthetic VSMCs ( Figure 1B and 1G ). In agreement with this pattern of activity in the I-1/PP1/PLB/SERCA signaling pathway, global SR Ca 2+ -ATPase activity was significantly decreased in synthetic VSMCs compared with contractile VSMCs ( Figure 1H ). The decrease in SR Ca 2+ -ATPase activity in synthetic VSMCs can be linked to the lack of SERCA2a expression and to the inhibitory effect of unphosphorylated PLB on SR Ca 2+ -ATPase. In addition, the expression of other markers of quiescent status such as cAMP-responsive element binding (CREB; Figure 1B and 1I), p53 (tumor suppressor gene), and p21 was also markedly reduced in synthetic SMCs ( Figure 1B) .
Loss of I-1 Leads to a Shift From Contractile to Synthetic VSMC Phenotype
To study the impact of the loss of I-1 on the VSMC phenotype, thoracic aortas of adult (6- -ATPase activity in I-1 KO mice thoracic aorta compared with WT mice was observed ( Figure 2H ), recapitulating the observations in human samples ( Figure 1 ).
Next, we analyzed the expression of markers of differentiated SMCs. We found that by immunoblot and immunostaining Figure 2N ). Furthermore, expression levels of CREB, p53, and p21 were significantly decreased in the aortic VSMCs of I-1 KO mice ( Figure 2A , 2O, 2P, and 2Q, respectively). These data likely indicate that the downregulation of these key modulators of SMC contraction in the aorta of I-1 KO mice reflects the shift between contractile and synthetic phenotypes and suggests that the loss of I-1 affects the differentiation of VSMCs and their ability to adjust the phenotype to the physiologically required contractile state. Apoptosis was also evaluated in aortic cross sections from I-1 KO and WT aortas using terminal deoxynucleotidyl transferase dUTP nick-end labeling. Numerous apoptotic cells were detected in the media of I-1 KO aortas compared with WT aortas ( Figure IIIF in the online-only Data Supplement).
Moreover, morphometric analysis revealed a marked increase in thoracic aortic thickness in I-1 KO mice ( Figure 3A and 3B). The phenotype observed in the vascular cells of I-1 KO mice, characterized by anarchic proliferation and apoptosis, can be described as a vascular proliferative disorder. We further investigated the proliferative capacities of VSMCs lacking I-1. To achieve this, left carotid artery injury with and without I-1c gene transfer was performed in adult (12 weeks old) WT and I-1 KO mice. The right carotid artery from WT was used as sham operated (no wire injury). One month after surgery, histological analysis revealed the presence of neointimal lesions in injured arteries of both mouse strains. Of note, the medial thickness of the carotid artery was already increased in noninjured carotids from I-1 KO mice ( Figure 3C and 3D) , confirming the observations made from thoracic aortas ( Figure 3B ). As expected, carotid injury induced medial and neointimal proliferation in both strains ( Figure 3D and 3E ), but the thickness was significantly greater in I-1 KO animals ( Figure 3E ). Overexpression of a truncated, constitutively active form of I-1 by an adenovirus (Ad.I-1c) by gene transfer markedly reduced the neointimal thickness in the injured WT carotid artery compared with WT nontransduced animals ( Figure 3D and 3E) . However, I-1c-infected I-1 KO did not significantly reduce postinjury neointimal proliferation, nor did it reduce medial cell proliferation compared WT I1c-infected mice ( Figure 3D and 3E), probably as a consequence of VSMC dedifferentiation. Analysis by immunofluorescence confirmed that injured left carotid arteries transduced with I-1c showed downregulation of markers of the contractile VSMCs phenotype such as SM-MHC and SERCA2a in I-1 KO mice compared with sham noninjured and WT infected carotid arteries after injury ( Figure IV in the online-only Data Supplement). These data demonstrate that VSMCs lacking I-1 proliferate readily and appear unable to adopt a quiescent state. Consistent with this, adult I-1-deficient mice develop a vascular proliferative disorder with excessive neointimal proliferation after vascular injury.
To assess the effects of I-1 gene ablation on endotheliumdependent contraction, mouse femoral arteries were stimulated with 1 μmol/L prostaglandin F2α, and measurements of outer vessel diameter were performed at different time points and compared with baseline ( Figure 3F ). Prostaglandin F2α, which is known to induce endothelium-dependent contractions, 32 resulted in significant modifications of contractile properties of femoral arteries of I-1 KO mice compared with WT ( Figure 3F ). Furthermore, analysis of the dose-response relationships to acetylcholine indicated a decrease in the strength of the response of the I-1 KO femoral arteries to endothelium-dependent relaxation at higher concentrations compared with WT mice ( Figure 3G ).
The Effect of I-1 on Calcium Signaling in VSMCs Is
SERCA2 Isoform Dependent
To determine whether I-1-dependent PLB phosphorylation plays a role in the control of SR Ca 2+ uptake and intracellular Ca 2+ transient, we overexpressed Ad.I-1c in synthetic cultured hCASMCs. 21 Of note, the ubiquitous SERCA2b is the only isoform expressed in these cells ( Figure 1B) . The expression of I-1c protein was observed (7 kDa; Figure 4A , left), whereas endogenous I-1 (28 kDa) was not detectable in synthetic hCASMCs overexpressing I-1c (not shown). Adenovirus-mediated gene transfer of I-1c (Ad.I-1c) significantly increased PLB phosphorylation at Ser16 ( Figure 4A ). However, I-1c overexpression had no effect on hCASMC proliferation ( Figure 4B Figure 4B ). These data indicate that to inhibit proliferation, I-1 needs the presence of SERCA2a.
Regulation of gene expression by Ca 2+ can be mediated by Ca 2+ -dependent phosphorylation of the transcription factor CREB. 33 Therefore, we hypothesized that I-1/CREB signaling might regulate the VSMC phenotype. In testing this hypothesis, we found that the expression levels of CREB phosphorylated on Ser133 and p21 were highly elevated in synthetic VSMCs co-overexpressing I-1c and SERCA2a ( Figure VA in the online-only Data Supplement). 10 Here, we examined the inositol triphosphate-induced Ca 2+ transients generated by agonist. In hCASMCs infected with Ad.β galactosiase (Ad.βGal), serum induced a long-lasting increase in cytosolic Ca 2+ as a result of SR Ca 2+ release ( Figure 4C ). The addition of Ca 2+ to the extracellular medium triggered SOC in these cells ( Figure 4C ). Similar transients were observed in control noninfected cells (not shown). Surprisingly, I-1c expression had no effect on Ca 2+ transients in synthetic hCASMCs ( Figure 4D and Figure  VIA -VID in the online-only Data Supplement). In line with this, the increase in PLB phosphorylation by I-1c expression ( Figure 4A ) had no effect on Ca 
Effect of I-1 on Ca 2+ Cycling and Signaling in Contractile and Synthetic Rat Aortic VSMCs
In the aforementioned adenovirus transduction experiments, we used a green fluorescent protein tag to identify infected cells. Because both viruses (Ad.SERCA2a and Ad.I-1c) were tagged with green fluorescent protein, we were unable to ascertain whether any given cell was infected with 1 or both viruses, even though the rate of infection for each virus was ≈80%. To avoid this uncertainty, we performed experiments using freshly dissociated contractile rat aortic VSMCs, expressing SERCA2a, and synthetic cultured rat aortic VSMCs, expressing mainly SERCA2b. 11, 14 The phenotypic status of the rat aortic VSMCs was verified by analyzing the expression of contractile proteins: smooth muscle α-actin, SM-MHC, and calponin (Figure VIIIA in the online-only Data Supplement). In parallel, the cyclin D1 protein level was increased in synthetic VSMCs ( Figure VIIIA in the onlineonly Data Supplement). By immunostaining, cyclin D1 was not detected in freshly dissociated VSMCs, confirming their nonproliferative contractile phenotype. Three days after induction of proliferation by serum (10% FBS), cyclin D1 was expressed, demonstrating the proliferative synthetic phenotype ( Figure VIIIB in the online-only Data Supplement). As expected, SERCA2a and I-1 were expressed in contractile VSMCs and downregulated in synthetic VSMCs ( Figure 5A and Figure VIIIB in the online-only Data Supplement). p21 and p53 expression, CREB phosphorylated on Ser133, and PLB phosphorylation were also decreased in rat synthetic VSMCs ( Figure 5A ).
The initial Ca 2+ event of VSMC dedifferentiation is the downregulation of Ca 2+ -ATPase activity, which results in a sustained increase in cytosolic Ca 2+ and increased calcineurin-NFAT activity.
11 Because I-1 downregulation is a part of the dedifferentiation process, we assessed the effect of I-1c overexpression on the dedifferentiation, proliferation, and Ca 2+ transient of contractile VSMCs. Immediately after dissociation of rat aortic VSMCs, contractile aortic VSMCs were infected with Ad.I-1c or βGal virus and analyzed at day 4 after infection in a high concentration of FBS (10%). Remarkably, expression of I-1c prevented dedifferentiation of contractile VSMCs induced by serum, as attested by a sustained increase in SERCA2a and SM-MHC mRNA expression ( Figure 5B ). As expected, exposure to serum induced proliferation of contractile VSMCs, with the percentage of proliferation being similar to that in synthetic VSMCs ( Figure 5C ). Infection of VSMCs with Ad.I-1c significantly reduced proliferation of contractile VSMCs without any effect on synthetic VSMC proliferation ( Figure 5C ). Of note, infection of contractile VSMCs with Ad.βGal had no effect on VSMC proliferation or on serum-induced dedifferentiation ( Figure 5B and 5C ). Next, we examined Ca 2+ transients in contractile and synthetic rat aortic VSMCs (Figure 5D-5I ). As expected, thrombin induced SR Ca 2+ release in contractile VSMCs with the inhibition of Ca 2+ entry by SOCE after the addition of Ca 2+ in the extracellular medium ( Figure 5D ). In contrast, in synthetic VSMCs, thrombin induced a large SR-released Ca 2+ transient followed by SOC after the addition of Ca 2+ ( Figure 5E ). Infection with control virus (Ad.βGal) had no effect on Ca 2+ transients in either contractile or synthetic VSMCs ( Figure 5F and 5G). Ad.I-1c overexpression had no effect on Ca 2+ transients in synthetic rat VSMCs stimulated with serum compared with controls ( Figure 5I and Figure IXB in the online-only Data Supplement) and in Ca 2+ remobilized when thapsigargin was added ( Figure IXC in the online-only Data Supplement), confirming the observations made for hCASMCs ( Figure 4D ). However, I-1c overexpression significantly decreased overall Ca 2+ transients in contractile rat VSMCs stimulated with serum ( Figure 5H and Figure IXA in the online-only Data Supplement), confirming that the effect of I-1 on Ca 2+ transients depends on SERCA2a isoform expression in contractile versus synthetic VSMCs.
Constitutively Active I-1 Prevents Postinjury Remodeling and Neointimal Proliferation in a Rat Carotid Injury Model
Because I-1c overexpression prevents dedifferentiation and proliferation of contractile VSMCs in vitro, we next tested the possibility that I-1c gene transfer may prevent postangioplasty neointimal proliferation. For this purpose, we performed balloon injury in the left carotid arteries of adult male rats, followed immediately by gene transfer of Ad.I-1c or Ad.βGal. The right carotid was used as sham operated, noninjured. Animals were euthanized 2 weeks after injury, and neointimal thickening was analyzed on hematoxylin and eosin-stained cross sections ( Figure 6A ). Infection was confirmed by polymerase chain reaction detection of green fluorescent protein DNA in the carotid arteries infected with Ad.I-1c compared with noninfected arteries (Figure X in the online-only Data Supplement). Injury induced abundant neointimal proliferation and an increase in the medial thickness in noninfected (saline) or Ad.βGal-infected arteries, whereas infection with Ad.I-1c significantly reduced medial thickening and prevented neointimal proliferation ( Figure 6B ). Analysis by immunofluorescence microscopy confirmed that in saline-and Ad.βGal-infected arteries, there was downregulation of I-1 in the injured carotid segments, as well as downregulation of markers of the contractile phenotype such as SM-MHC and SERCA2a ( Figure 7A ). In contrast, in Ad.I-1c-infected arteries, I-1 expression was detected; however, our antibody does not allow us to discriminate between the endogenous and the transgene I-1 protein. Nevertheless, expression of SERCA2a and SM-MHC was preserved in I-1c-infected arteries ( Figure 7A ). In addition, the expression of CREB and p21 was lower in the media and adventitia of βGal-infected carotid arteries compared with arteries treated with Ad.I-1c. However, NFAT expression was highly increased in the βGal-compared with the I-1c-infected injured carotid ( Figure 7B ). Thus, I-1c prevented dedifferentiation and proliferation of contractile VSMCs expressing SERCA2a but had no effect on synthetic VSMCs, which predominantly express the SERCA2b isoform and NFATC3.
Discussion
The important finding of the present study is that PKA/I-1 downstream signaling pathways are organized differently in contractile and synthetic VSMCs (Figure 8 ). This signaling specificity is supported by altered expression of molecules involved in the regulation of the downstream of the cAMP/PKA signaling cascade, with I-1 and PP1 possibly providing of dual control of the signaling pathway at both the protein expression and phosphorylation levels. We demonstrated mirrored expression of I-1 and PP1 within contractile and synthetic VSMCs, leading to the enhancement of the PKA pathway in contractile VSMCs. I-1 is more highly expressed in the media of human coronary and freshly dispersed rat aortic VSMCs than in their cultured counterparts. The expression of I-1 correlated closely with the expression of genes for contractile proteins: smooth muscle α-actin (SMA), calponin, SERCA2a, and the by guest on November 16, 2017 http://circ.ahajournals.org/ Downloaded from SM-MHC proteins, which are also downregulated in synthetic dedifferentiated VSMCs. 15 Therefore, these results establish a clear link between the differentiated, contractile phenotype of VSMCs and the downregulation of I-1 in rat and human VSMCs, suggesting a possible role for I-1 in the maintenance or function of the differentiated VSMC phenotype.
Moreover, we showed that VSMCs obtained from I-1KO mice are in a proliferative state and display the characteristics More interestingly, in contrast to PP1, SERCA2a protein levels, together with PLB phosphorylation and therefore Ca 2+ -ATPase, were reduced. However, when constitutively active I-1 is overexpressed, SERCA2a activity can be further increased. We also demonstrated that in vivo gene transfer of constitutively active I-1c prevents VSMC dedifferentiation and neointimal formation in a rat and mouse carotid injury model. However, in I-1 KO mice, because the VSMCs are dedifferentiated, neointimal formation was not decreased after I-1c overexpression. Thus, I-1 and SERCA2a are necessary and act synergistically to regulate the VSMC phenotype. A further interesting observation that can be drawn from the I-1 KO mice is the increase in aortic thickness resulting from hyperplasia and the excessive neointimal formation with vascular injury in vivo.
The results presented here demonstrate that loss of I-1 in a mouse model increases SMC proliferation. These data support the hypothesis that a hyperplastic response modulated by I-1 in VSMCs contributes to vascular disease. In the heart, I-1 was found to be downregulated and hypophosphorylated in human and experimental heart failure but hyperactive in human atrial fibrillation, implicating I-1 in the pathogenesis of heart failure and arrhythmias. 34 In addition, constitutive I-1c expression by gene transfer restored contractile properties in failing rat hearts and failing human cardiac myocytes. 21, 22 In our study, we showed that I-1c overexpression in carotid artery injury models prevented the downregulation of the expression of VSMC contractile markers such as SERCA2a and SM-MHC, as well as CREB and p21 expression. Several studies have also shown that downregulation of CREB expression or phosphorylation is associated with elevated cardiovascular risk markers in rodent models. 35 Indolfi et al 36 have reported that PKA signaling inhibits neointimal formation after vascular injury in vivo as a model of restenosis after angioplasty. In addition, cAMP signaling in SMCs has been shown to decrease the expression of cyclin D1 37 and to increase the expression of antiproliferative regulators like p53 and p21. 38 Furthermore, I-1c overexpression in contractile VSMCs also decreased transcription factor NFAT activity required for proliferation and migration of VSMCs that express SERCA2a. 13, 15 We have shown that the restoration of SERCA2a expression by gene transfer in synthetic VSMCs was sufficient to block their proliferation and migration via inhibition of NFAT 15 ; however, it will be interesting to assess whether SERCA2a gene transfer restores the I-1 expression level. The molecular mechanisms of this effect are related to the prevention of a functional association between STIM1 and OraI-1 (CRAC protein entity), which leads to the suppression of SOCE channel influx. 15 It is worth mentioning that SOC influx after agonist stimulation is not observed in contractile VSMCs, which express SERCA2a and I-1, compared with synthetic VSMCs. This suggests that I-1 exerts its effects through SERCA2a.
In addition, I-1 KO femoral arteries in vivo displayed a significantly lower vasoconstriction and vasorelaxation response compared with WT. These results suggest that changes in I-1 expression can modify the VSMC phenotype and therefore VSMC contractility. Indeed, the loss of I-1 in synthetic VSMCs and in the mouse model is associated with a reduced SR Ca 2+ -ATPase activity. Therefore, I-1 is a critical determinant of SR Ca 2+ uptake function. These results are particularly interesting when considered along with recent results demonstrating reduced endothelium-dependent relaxation in mice deficient in the SERCA3 isoform. 39 Another study showed that deletion of PLB can also reduce endotheliumdependent relaxation. 40 However, yet another study has suggested that ablation of I-1 does not play a major role in either tonic or phasic SM contractility in vivo. In that report, although I-1 did not have any major effects on the aorta, there was a significant, rightward-shifted (desensitized) response to isoproterenol in I-1 KO portal veins. 21 The difference between that study and our findings may potentially be attributable to the fact that our experiments were carried out in femoral arteries in vivo and the published study was done on mounted, isolated, denuded aortic rings. 21 In theory, the organization of the PKA/I-1 signaling pathway should increase SERCA2a activity in contractile VSMCs while inhibiting SERCA2a activity in synthetic cells. However, in reality, SERCA2a activity is further distinguished between contractile and synthetic VSMCs by SERCA2 isoform expression levels. In accordance with our previous observations, 10 . Therefore, the interplay between Ca 2+ release and uptake systems is an important determinant of endothelial steady-state Ca 2+ levels that elicits endothelium-dependent relaxation. Our study also shows that knockdown of PP1 enhances hyperphosphorylation of PLB and CREB and decreases NFAT activity. Our results provide further evidence for a role of PP1 pathway in regulating the dephosphorylation of Ser133 and thereby limiting CREB transcriptional activity in synthetic VSMCs. Many studies have shown that increased PP1 activity is closely associated with the progression of heart failure. 16, 22, 41 PP1, a haloenzyme, consists of 3 distinct genes: PP1c-alpha (PP1α), PP1c-gamma (PP1λ), which gives rise to 2 splice variants (PP1c-λ1 and PP1c-λa2), and PP1c-beta/delta (PP1β), [42] [43] [44] the functions of which are not well characterized in cardiovascular cells. In our study, we found that PP1α and PP1β are increased in synthetic VSMCs. PP1β expression has been shown to gradually increase during the progressive time course of cardiac dysfunction in cardiomyopathic hamsters. 41 The expression levels of PP1β may have a crucial impact on SR Ca 2+ cycling. The PP1β isoform was shown to be highly expressed in the longitudinal SR and formed a molecular complex with PLB and SERCA2a. Moreover, PP1β is the most significantly involved PP1 isoform in regulating PLB phosphorylation at Ser16 in the longitudinal SR, thereby controlling SR-mediated Ca 2+ cycling in cardiomyocytes. 45 
Conclusions
We have demonstrated for the first time that Ca 2+ signaling pathways via the I-1/PP1 signaling pathway are altered in synthetic VSMCs. I-1 expression appears to be a robust marker for contractile VSMCs, whereas PP1 expression is specific for synthetic VSMCs, thus reinforcing our finding of altered Ca 2+ signaling. Furthermore, the synergistic action of I-1 and SERCA2a is necessary for the acquisition of high SERCA2a activity required for the contractile phenotype. Gene transfer of constitutive active I-1c to contractile VSMCs prevents injury-induced dedifferentiation and neointimal proliferations of VSMCs. Collectively, these data suggest that I-1c gene transfer may be considered as a therapeutic strategy for preventing vascular proliferative disorders.
Sources of Funding
This work was supported by the American Heart Association grant SDG 0930116 N (Dr Lipskaia); National Heart, Lung, and Blood Institute grants K01 HL1031176-01 (Dr Hadri), K08HL111330 (Dr Kovacic,), and R01 HL080498 and R01 HL083156 (Dr Hajjar); by the Association Française Contre les Myopathies (Dr Bobe); by AFM16442 (Drs Bobe, Lipskaia, Lopez, and Hajjar); and by MEC-FEDER (BFU2010-C02-01; Drs Bobe and Lopez). Dr Lopez was supported by a postdoctoral fellowship from the Junta de Extremadura (POS0922).
Disclosures
Dr Hajjar is a scientific founder of Celladon Corp, which plans to commercialize AAV1.SERCA2a for the treatment of heart failure. The other authors report no conflicts.
CLINICAL PERSPECTIVE
Phenotypic switching of vascular smooth muscle cells (VSMCs) from a contractile/quiescent to a proliferative/synthetic phenotype plays a key role in vascular proliferative syndromes such as atherosclerosis and restenosis. VSMC phenotype switch is associated with alterations of VSMC Ca 2+ handling proteins. Recently, we demonstrated that Ca 2+ cycling in contractile VSMCs requires the expression of the sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) isoform SERCA2a. Protein phosphatase inhibitor-1 (I-1), a highly specific inhibitor of protein phosphatase 1, enhances protein kinase A-dependent phospholamban phosphorylation and therefore SERCA2a activity. In the present study, we examined the role of I-1 in the VSMC phenotype switch and the therapeutic potential of constitutively active I-1 (I1c) gene transfer in a postangioplasty restenosis model. In human coronary arteries, we showed that I-1 expression is specific to contractile VSMCs; however, in synthetic VSMCs, I-1 expression was significantly decreased, leading to an increase in its target PP1 and a decrease in phospholamban phosphorylation and SERCA2 activity. In cells coexpressing I-1c and SERCA2a, VSMC proliferation was decreased with an increase in Ca 2+ uptake and sarco/endoplasmic reticulum Ca 2+ load. I-1 knockout mice lack phospholamban phosphorylation and exhibit VSMC arrest in the synthetic state, with a significant modification of contractile properties and relaxant response of femoral artery in vivo and an excessive neointimal proliferation after carotid injury. Local I-1c gene transfer in a rat model of carotid injury decreased neointimal formation by preserving VSMC contractile marker expression and therefore preventing VSMC phenotypic switch. Gene transfer of I1c may be considered a therapeutic strategy for preventing vascular proliferative disorders. Histological analysis. The morphology of the aorta and carotid arteries was analyzed on hematoxylin/eosin stained cross-sections. The medial and neointimal areas were measured with a computer-based morphometric system (cellSens Entry software, Olympus) and calculated using Image J software. For each vessel, 5 discontinuous sections were analyzed.
